Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.
Saved in:
| Title: | Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study. |
|---|---|
| Authors: | Álvarez H; Department of Internal Medicine, Infectious Diseases Unit, Complexo Hospitalario Universitario de Ferrol, Ferrol, SERGAS-A Coruña, Spain.; Department of Biochemistry, Genetics and Immunology, Universidade de Vigo, Vigo, Spain., Mocroft A; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Ryom L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Infectious Diseases, Hvidovre University Hospital, Copenhagen, Denmark., Neesgaard B; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Edwards S; Department of HIV, Mortimer Market Centre, London, United Kingdom., Svedhem V; Department of Medicine, Medical Unit Infectious Diseases, Karolinska University Hospital, Karolinska Institutet, Huddinge, Sweden., Günthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Zangerle R; Austrian HIV Cohort Study, Medizinische Universität Innsbruck, Innsbruck, Austria., Smith C; The Royal Free HIV Cohort Study, Royal Free Hospital, University College London, London, United Kingdom., Castagna A; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy., d'Arminio Monforte A; Italian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milano, Italy., Wit F; AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands., Stecher M; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany., Lehman C; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany., Mussini C; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy., Fontas E; Nice HIV Cohort, Université Côte d´Azur et Centre Hospitalier Universitaire, Nice, France., González E; PISCIS Cohort Study, Centre Estudis Epidemologics de ITS i VIH de Catalunya, Badalona, Spain., Wasmuth JC; Medical Department, University Hospital Bonn, Bonn, Germany., Sönnerborg A; Swedish InfCare HIV Cohort, Karolinska University Hospital, Stockholm, Sweden., De Wit S; CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium., Chkhartishvili N; Georgian National AIDS Health Information System, Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia., Stephan C; Frankfurt HIV Cohort Study, University Hospital Frankfurt, Goethe-University, Infectious Diseases Unit, Frankfurt, Germany., Petoumenos K; The Kirby Institute, University of New South Wales, Sydney, Australia., Jaschinski N; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Vannappagari V; ViiV Healthcare, Research Triangle Park, North Carolina, USA., Gallant J; Gilead Sciences, Foster City, California, USA., Young L; Merck Sharp & Dohme, Luzern, Switzerland., Volny Anne A; European AIDS Treatment Group, Brussels, Belgium., Greenberg L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Martín-Iguacel R; Infectious Diseases Department, Odense University Hospital, Odense, Denmark., Poveda E; Group of Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, Vigo, SERGAS-UVigo, Spain., Llibre JM; Infectious Diseases Division and Fight Infections Foundation, University Hospital Germans Trias i Pujol, Barcelona, Spain. |
| Corporate Authors: | RESPOND (International Cohort Consortium of Infectious Diseases) Study Group |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Aug 22; Vol. 77 (4), pp. 593-605. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37052343 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Álvarez+H%22">Álvarez H</searchLink>; Department of Internal Medicine, Infectious Diseases Unit, Complexo Hospitalario Universitario de Ferrol, Ferrol, SERGAS-A Coruña, Spain.; Department of Biochemistry, Genetics and Immunology, Universidade de Vigo, Vigo, Spain.<br /><searchLink fieldCode="AU" term="%22Mocroft+A%22">Mocroft A</searchLink>; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ryom+L%22">Ryom L</searchLink>; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Infectious Diseases, Hvidovre University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Neesgaard+B%22">Neesgaard B</searchLink>; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Edwards+S%22">Edwards S</searchLink>; Department of HIV, Mortimer Market Centre, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Svedhem+V%22">Svedhem V</searchLink>; Department of Medicine, Medical Unit Infectious Diseases, Karolinska University Hospital, Karolinska Institutet, Huddinge, Sweden.<br /><searchLink fieldCode="AU" term="%22Günthard+HF%22">Günthard HF</searchLink>; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Zangerle+R%22">Zangerle R</searchLink>; Austrian HIV Cohort Study, Medizinische Universität Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Smith+C%22">Smith C</searchLink>; The Royal Free HIV Cohort Study, Royal Free Hospital, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Castagna+A%22">Castagna A</searchLink>; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22d'Arminio+Monforte+A%22">d'Arminio Monforte A</searchLink>; Italian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Wit+F%22">Wit F</searchLink>; AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Stecher+M%22">Stecher M</searchLink>; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Lehman+C%22">Lehman C</searchLink>; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Mussini+C%22">Mussini C</searchLink>; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy.<br /><searchLink fieldCode="AU" term="%22Fontas+E%22">Fontas E</searchLink>; Nice HIV Cohort, Université Côte d´Azur et Centre Hospitalier Universitaire, Nice, France.<br /><searchLink fieldCode="AU" term="%22González+E%22">González E</searchLink>; PISCIS Cohort Study, Centre Estudis Epidemologics de ITS i VIH de Catalunya, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Wasmuth+JC%22">Wasmuth JC</searchLink>; Medical Department, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Sönnerborg+A%22">Sönnerborg A</searchLink>; Swedish InfCare HIV Cohort, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22De+Wit+S%22">De Wit S</searchLink>; CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Chkhartishvili+N%22">Chkhartishvili N</searchLink>; Georgian National AIDS Health Information System, Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.<br /><searchLink fieldCode="AU" term="%22Stephan+C%22">Stephan C</searchLink>; Frankfurt HIV Cohort Study, University Hospital Frankfurt, Goethe-University, Infectious Diseases Unit, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Petoumenos+K%22">Petoumenos K</searchLink>; The Kirby Institute, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Jaschinski+N%22">Jaschinski N</searchLink>; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Vannappagari+V%22">Vannappagari V</searchLink>; ViiV Healthcare, Research Triangle Park, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Gallant+J%22">Gallant J</searchLink>; Gilead Sciences, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Young+L%22">Young L</searchLink>; Merck Sharp & Dohme, Luzern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Volny+Anne+A%22">Volny Anne A</searchLink>; European AIDS Treatment Group, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Greenberg+L%22">Greenberg L</searchLink>; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Martín-Iguacel+R%22">Martín-Iguacel R</searchLink>; Infectious Diseases Department, Odense University Hospital, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Poveda+E%22">Poveda E</searchLink>; Group of Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, Vigo, SERGAS-UVigo, Spain.<br /><searchLink fieldCode="AU" term="%22Llibre+JM%22">Llibre JM</searchLink>; Infectious Diseases Division and Fight Infections Foundation, University Hospital Germans Trias i Pujol, Barcelona, Spain. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22RESPOND+%28International+Cohort+Consortium+of+Infectious+Diseases%29+Study+Group%22">RESPOND (International Cohort Consortium of Infectious Diseases) Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2023 Aug 22; Vol. 77 (4), pp. 593-605. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37052343 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cid/ciad219 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 593 Titles: – TitleFull: Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Álvarez H – PersonEntity: Name: NameFull: Mocroft A – PersonEntity: Name: NameFull: Ryom L – PersonEntity: Name: NameFull: Neesgaard B – PersonEntity: Name: NameFull: Edwards S – PersonEntity: Name: NameFull: Svedhem V – PersonEntity: Name: NameFull: Günthard HF – PersonEntity: Name: NameFull: Zangerle R – PersonEntity: Name: NameFull: Smith C – PersonEntity: Name: NameFull: Castagna A – PersonEntity: Name: NameFull: d'Arminio Monforte A – PersonEntity: Name: NameFull: Wit F – PersonEntity: Name: NameFull: Stecher M – PersonEntity: Name: NameFull: Lehman C – PersonEntity: Name: NameFull: Mussini C – PersonEntity: Name: NameFull: Fontas E – PersonEntity: Name: NameFull: González E – PersonEntity: Name: NameFull: Wasmuth JC – PersonEntity: Name: NameFull: Sönnerborg A – PersonEntity: Name: NameFull: De Wit S – PersonEntity: Name: NameFull: Chkhartishvili N – PersonEntity: Name: NameFull: Stephan C – PersonEntity: Name: NameFull: Petoumenos K – PersonEntity: Name: NameFull: Jaschinski N – PersonEntity: Name: NameFull: Vannappagari V – PersonEntity: Name: NameFull: Gallant J – PersonEntity: Name: NameFull: Young L – PersonEntity: Name: NameFull: Volny Anne A – PersonEntity: Name: NameFull: Greenberg L – PersonEntity: Name: NameFull: Martín-Iguacel R – PersonEntity: Name: NameFull: Poveda E – PersonEntity: Name: NameFull: Llibre JM IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 08 Text: 2023 Aug 22 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1537-6591 Numbering: – Type: volume Value: 77 – Type: issue Value: 4 Titles: – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Type: main |
| ResultId | 1 |